Haluk Topaloğlu - Concepedia

Author

Haluk Topaloğlu

Also Known As

Edward Smith, H Topaloglu, H Topaloğlu, H Topaloǧlu, H. TOPALOĞLU, H. Topaloglu, H. Topaloĝlu, H. Topaloğlu, H. Topaloǧlu, H. Topaloglu

506

Publications

22.3K

Citations

H-Index

199

Concepts

All Affiliations

Hacettepe University Hacettepe University Hospital Inserm Sorbonne Université Institut de Myologie

About

Haluk Topaloğlu is an author at Hacettepe University specializing in medicine, genetics, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	125	12.1K
2	Health Sciences	12	12	1.2K
3	Public Health	5	5	180
4	Engineering	2	2	995
5	Natural Sciences	2	2	155

Haluk Topaloğlu

194

Publications

20.3K

Citations

H-Index

Page 1

	Year	Citations
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel, Eugenio Mercuri, Basil T. Darras, New England Journal of Medicine	2017	2.2K
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations Catherine L. Bladen, David Salgado, Soledad Monges, Human Mutation Dmd MutationsTrial PlanningEngineeringMendelian DisorderGenetic Disorder	2015	717
Muscular Dystrophy and Neuronal Migration Disorder Caused by Mutations in a Glycosyltransferase, POMGnT1 Aruto Yoshida, Kazuhiro Kobayashi, Hiroshi Manya, Developmental Cell Mendelian DisorderNeuronal Migration DisorderGenetic DisorderMedicineGenetics	2001	707
Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy A. Leclerc, Xu Zhang, Haluk Topaloğlu, Nature Genetics Rare DiseasesLaminin α2–Chain GeneDevelopmental BiologyGenetic DisorderMedicine	1995	624
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study Darryl C. De Vivo, Enrico Bertini, Kathryn J. Swoboda, Neuromuscular Disorders Spinal DisorderPediatricsNurture StudySpinal Muscular AtrophyNeurology	2019	602
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, Journal of the Peripheral Nervous System	2021	461
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, The Lancet Rare DiseasesUrologyClinical TrialsDegenerative DiseaseRehabilitation	2017	446
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan C. Godfrey, Emma Clement, R. Mein, Brain	2007	433
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, European Journal of Neurology	2021	416
The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy Pascale Bomont, L Cavalier, F Blondeau, Nature Genetics NeuroregenerationMolecular NeuroscienceGiant Axonal NeuropathyNeuroanatomyExperimental Neuropathology	2000	410

Page 1